Building the Future of Pharmaceutical Cannabis
PurePath Pharma Ltd is a medical cannabis export company headquartered in Thailand, with operations in the United Kingdom and expanding to Germany and Australia. We specialize in pharmaceutical-grade medical cannabis supply for global pharmaceutical partners.
Our Mission
To provide pharmaceutical-grade medical cannabis to global healthcare markets through rigorous quality systems, regulatory excellence, and reliable supply chain operations.
Our Vision
To be the trusted partner of choice for pharmaceutical companies seeking compliant, high-quality medical cannabis supply from Southeast Asia.
Our Values
Quality without compromise. Transparency in every interaction. Partnership built on trust. Innovation guided by science. Compliance as our foundation.
From Thailand to the World
PurePath Pharma was founded with a clear vision: to bridge Thailand's exceptional cultivation conditions with the stringent requirements of global pharmaceutical markets. Our founders recognized that the future of medical cannabis lies in pharmaceutical-grade quality and regulatory compliance.
With headquarters in Bangkok, Thailand, we have established a comprehensive supply chain that encompasses GACP-aligned cultivation, quality-controlled processing, and GDP-compliant logistics. Our European presence through our UK office enables us to work closely with pharmaceutical partners across the continent.
Today, we are expanding our operations to Germany and Australia, strengthening our ability to serve the growing global demand for pharmaceutical-grade medical cannabis.

Our Locations
Strategically positioned to serve pharmaceutical markets worldwide with local expertise and global capabilities.
Thailand
Head Office & Cultivation
OperationalUnited Kingdom
European Operations
OperationalGermany
Market Expansion
ExpandingAustralia
APAC Operations
ExpandingOur Competitive Advantage
Thailand Cost Base + Climate
Optimal growing conditions combined with competitive production costs, while maintaining pharmaceutical-grade controls.
Fresh Genetics Program
Documented stability, consistent cannabinoid/terpene profiles, and proprietary cultivar development.
Speed to Market
Air-cargo model with GDP packaging and temperature/humidity controls for rapid, reliable delivery.
Transparency & Documentation
More technical documentation than competitors, enabling faster regulatory approvals and partner confidence.